In Wednesday's "Need to Know" column, Barbara Kollmeyer shared words of wisdom from Larry Swedroe, who has written many books about investing during a long career managing money. He quoted Buffett and ...

The GLP-1 ad wars “Healthy Skepticism” comes weeks after Eli Lilly competitor and Ozempic-maker Novo Nordisk launched a print ...

The costs of blockbuster weight-loss drugs, projected to double again this year, will likely boost premiums for Blue Cross ...

Ozempic and its ilk may do a lot of things, but raising the risk of suicide doesn’t appear to be one of them. Research out ...

Jab for joy? A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have “an antidepressant effect,” suggesting ...

Billy Joel has been performing his hit songs all over the world for decades, but a recent concert in Connecticut didn't go as ...

The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw ...

Blue Cross Blue Shield of Massachusetts, the largest insurer in the state, reported its largest operating loss in the ...

Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.

Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. | Once ...

Global Partners LP Common Units ( NYSE: GLP) Q4 2024 Earnings Conference Call February 28, 2025 10:00 AM ET Sean Geary - CLO & Secretary Eric Slifka - President & CEO Gregory Hanson - CFO Mark Romaine ...

Age differences are seen in the efficacy of treatments for type 2 diabetes, according to study results published in the Journal of the AMA.